Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum

Abstract Background In the current scenario, designing of world-wide effective malaria vaccine against Plasmodium falciparum remain challenging despite the significant progress has been made in last few decades. Conventional vaccinology (isolate, inactivate and inject) approaches are time consuming,...

Full description

Bibliographic Details
Main Authors: Manisha Pritam, Garima Singh, Suchit Swaroop, Akhilesh Kumar Singh, Satarudra Prakash Singh
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Bioinformatics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12859-018-2482-x
id doaj-308f76168e194583be30811772bb6907
record_format Article
spelling doaj-308f76168e194583be30811772bb69072020-11-25T02:51:12ZengBMCBMC Bioinformatics1471-21052019-02-0119S1321923010.1186/s12859-018-2482-xExploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparumManisha Pritam0Garima Singh1Suchit Swaroop2Akhilesh Kumar Singh3Satarudra Prakash Singh4Amity Institute of Biotechnology, Amity University Uttar PradeshAmity Institute of Biotechnology, Amity University Uttar PradeshDepartment of Zoology, University of LucknowAmity Institute of Biotechnology, Amity University Uttar PradeshAmity Institute of Biotechnology, Amity University Uttar PradeshAbstract Background In the current scenario, designing of world-wide effective malaria vaccine against Plasmodium falciparum remain challenging despite the significant progress has been made in last few decades. Conventional vaccinology (isolate, inactivate and inject) approaches are time consuming, laborious and expensive; therefore, the use of computational vaccinology tools are imperative, which can facilitate the design of new and promising vaccine candidates. Results In current investigation, initially 5548 proteins of P. falciparum genome were carefully chosen for the incidence of signal peptide/ anchor using SignalP4.0 tool that resulted into 640 surface linked proteins (SLP). Out of these SLP, only 17 were predicted to contain GPI-anchors using PredGPI tool in which further 5 proteins were considered as malarial antigenic adhesins by MAAP and VaxiJen programs, respectively. In the subsequent step, T cell epitopes of 5 genome derived predicted antigenic adhesins (GDPAA) and 5 randomly selected known malarial adhesins (RSKMA) were analysed employing MHC class I and II tools of IEDB analysis resource. Finally, VaxiJen scored T cell epitopes from each antigen were considered for prediction of population coverage (PPC) analysis in the world-wide population including malaria endemic regions. The validation of the present in silico strategy was carried out by comparing the PPC of combined (MHC class I and II) predicted epitope ensemble among GDPAA (99.97%), RSKMA (99.90%) and experimentally known epitopes (EKE) of P. falciparum (97.72%) pertaining to world-wide human population. Conclusions The present study systematically screened 5 potential protective antigens from P. falciparum genome using bioinformatics tools. Interestingly, these GDPAA, RSKMA and EKE of P. falciparum epitope ensembles forecasted to contain highly promiscuous T cell epitopes, which are potentially effective for most of the world-wide human population with malaria endemic regions. Therefore, these epitope ensembles could be considered in near future for novel and significantly effective vaccine candidate against malaria.http://link.springer.com/article/10.1186/s12859-018-2482-xMalariaAntigenEpitopesPopulation coverageVaccinePlasmodium falciparum
collection DOAJ
language English
format Article
sources DOAJ
author Manisha Pritam
Garima Singh
Suchit Swaroop
Akhilesh Kumar Singh
Satarudra Prakash Singh
spellingShingle Manisha Pritam
Garima Singh
Suchit Swaroop
Akhilesh Kumar Singh
Satarudra Prakash Singh
Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
BMC Bioinformatics
Malaria
Antigen
Epitopes
Population coverage
Vaccine
Plasmodium falciparum
author_facet Manisha Pritam
Garima Singh
Suchit Swaroop
Akhilesh Kumar Singh
Satarudra Prakash Singh
author_sort Manisha Pritam
title Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
title_short Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
title_full Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
title_fullStr Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
title_full_unstemmed Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
title_sort exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against plasmodium falciparum
publisher BMC
series BMC Bioinformatics
issn 1471-2105
publishDate 2019-02-01
description Abstract Background In the current scenario, designing of world-wide effective malaria vaccine against Plasmodium falciparum remain challenging despite the significant progress has been made in last few decades. Conventional vaccinology (isolate, inactivate and inject) approaches are time consuming, laborious and expensive; therefore, the use of computational vaccinology tools are imperative, which can facilitate the design of new and promising vaccine candidates. Results In current investigation, initially 5548 proteins of P. falciparum genome were carefully chosen for the incidence of signal peptide/ anchor using SignalP4.0 tool that resulted into 640 surface linked proteins (SLP). Out of these SLP, only 17 were predicted to contain GPI-anchors using PredGPI tool in which further 5 proteins were considered as malarial antigenic adhesins by MAAP and VaxiJen programs, respectively. In the subsequent step, T cell epitopes of 5 genome derived predicted antigenic adhesins (GDPAA) and 5 randomly selected known malarial adhesins (RSKMA) were analysed employing MHC class I and II tools of IEDB analysis resource. Finally, VaxiJen scored T cell epitopes from each antigen were considered for prediction of population coverage (PPC) analysis in the world-wide population including malaria endemic regions. The validation of the present in silico strategy was carried out by comparing the PPC of combined (MHC class I and II) predicted epitope ensemble among GDPAA (99.97%), RSKMA (99.90%) and experimentally known epitopes (EKE) of P. falciparum (97.72%) pertaining to world-wide human population. Conclusions The present study systematically screened 5 potential protective antigens from P. falciparum genome using bioinformatics tools. Interestingly, these GDPAA, RSKMA and EKE of P. falciparum epitope ensembles forecasted to contain highly promiscuous T cell epitopes, which are potentially effective for most of the world-wide human population with malaria endemic regions. Therefore, these epitope ensembles could be considered in near future for novel and significantly effective vaccine candidate against malaria.
topic Malaria
Antigen
Epitopes
Population coverage
Vaccine
Plasmodium falciparum
url http://link.springer.com/article/10.1186/s12859-018-2482-x
work_keys_str_mv AT manishapritam exploitationofreversevaccinologyandimmunoinformaticsaspromisingplatformforgenomewidescreeningofneweffectivevaccinecandidatesagainstplasmodiumfalciparum
AT garimasingh exploitationofreversevaccinologyandimmunoinformaticsaspromisingplatformforgenomewidescreeningofneweffectivevaccinecandidatesagainstplasmodiumfalciparum
AT suchitswaroop exploitationofreversevaccinologyandimmunoinformaticsaspromisingplatformforgenomewidescreeningofneweffectivevaccinecandidatesagainstplasmodiumfalciparum
AT akhileshkumarsingh exploitationofreversevaccinologyandimmunoinformaticsaspromisingplatformforgenomewidescreeningofneweffectivevaccinecandidatesagainstplasmodiumfalciparum
AT satarudraprakashsingh exploitationofreversevaccinologyandimmunoinformaticsaspromisingplatformforgenomewidescreeningofneweffectivevaccinecandidatesagainstplasmodiumfalciparum
_version_ 1724735790232109056